{
    "2021-07-06": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Oracle Stock Rides Higher With Relative Strength Rating Upgrade",
                "features": {
                    "keywords": [
                        "Oracle",
                        "Relative Strength Rating",
                        "Upgrade"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "The Zacks Analyst Blog Highlights: Oracle, Lockheed Martin, Boston Scientific, Regeneron Pharmaceuticals and Eni",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Oracle",
                        "Lockheed Martin",
                        "Boston Scientific",
                        "Regeneron Pharmaceuticals",
                        "Eni"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "defense",
                        "healthcare",
                        "pharmaceuticals",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}